Legal attitude: Art. 17 para. 1 MAR - confidential information. Br> The Management Board of Athos Venture Capital S.A. with its registered office in Warsaw (hereinafter: the Issuer), informs that yesterday (December 21, 2017) it concluded with a company in which it holds 36% of shares in the share capital, ie with Boruta - Zachem Biochemia sp. o.o. with the registered office in Bydgoszcz (KRS number: 0000568433) a loan agreement under which he lent to the company PLN 1,150,000.00 (one million one hundred and fifty thousand zlotys). br> The loan was granted for the implementation of Boruta - Zachem Biochemia sp. o.o. biochemical projects. The loan repayment date has been determined until 31 December 2018, with the possibility of early repayment. The loan bears interest at a variable interest rate, and its security is the Borrower's own promissory note. br> The Issuer also informs that it is another loan granted to Boruta - Zachem Biochemia sp. o.o. On the previous loans of the Issuer reported in the interim report for the third quarter of 2017 on November 14, 2017 - EBI No. 11/2017 (loan PLN 1 million) and ESPI report No. 17/2017 from December 20, 2017 (loan 2 PLN 85 million). br> The basis for the agreement being considered significant is the fact that the total amount of loans granted to Boruta - Zachem Biochemia sp. o.o. currently amounts to PLN 5,000,000.00 (five million zlotys), which exceeds 20% of the Issuer's equity. The Issuer does not exclude the possibility of granting further loans to the indicated entity, which may be reported in a relevant report. br> The loan granted will not adversely affect the Issuer's financial liquidity. Br>
Source: company website, investor relations, current and periodic reports.